
Elvina Almuradova/LinkedIn
Apr 16, 2025, 16:20
Elvina Almuradova: ASCO recommendations on stage III NSCLC
Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology (IEO), shared a post on X about a paper by Navneet Singh et al. published in JCO Oncology Practice:
“Stage III non–small cell lung cancer (NSCLC) is a highly heterogeneous disease requiring a multidisciplinary approach.
Recent ASCO recommendations highlight this complexity!”
Authors: Navneet Singh, Martin Früh, Matthew Gubens, Nofisat Ismaila, Megan Daly.
More posts featuring Elvina Almuradova.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 19, 2025, 17:17
Apr 19, 2025, 17:01
Apr 19, 2025, 16:44
Apr 19, 2025, 16:23
Apr 19, 2025, 16:09